Hox-like homeodomain proteins play a critical role during embryonic development by regulating the transcription of genes that are important for the generation of specific organs or cell types.
SUMMARY
Hox-like homeodomain proteins play a critical role during embryonic development by regulating the transcription of genes that are important for the generation of specific organs or cell types.
The homeodomain transcription factor IDX1/IPF1, whose expression was thought until recently to be restricted to the pancreas and foregut, is required for pancreas development and for the expression of genes controlling glucose homeostasis. We report that IDX1/IPF1 is also expressed in embryonic rat brain at a time coincident with active neurogenesis. Electrophoretic mobility shift assays with nuclear extracts of embryonic brains indicated that IDX1/IPF1 binds to two somatostatin promoter elements, SMS-UE-B and the recently discovered SMS-TAAT3. The requirement of these elements for IDX1/IPF1 transactivation of the somatostatin gene in neural cells was confirmed in transfection studies using embryonic cerebral cortex-derived RC2.E10 cells. Immunohistochemical staining of rat embryos showed IDX1/IPF1-positive cells located near the ventricular surface in germinative areas of the developing central nervous system. Cellular colocalization of IDX1/IPF1 and somatostatin was found in several areas of the developing brain, including cortex, ganglionic eminence, hypothalamus and inferior colliculus.
These results support the notion that IDX1/IPF1 regulates gene expression during development of the central nervous system independently of its role on pancreas development and function.
INTRODUCTION
Homeodomain genes encode a large family of transcription factors that are grouped in diferent classes, including, for example, Hox-, POU-, Pax-, LIM-, and Dlx-like proteins, depending on the relative degree of conservation of the homeodomain. During gestation, expression of individual homeodomain genes is critical for proper regional development of the central nervous system (CNS) and peripheral tissues of the embryo. IDX1/IPF1 (also known as STF-1 and PDX-1) is a transcription factor encoded by a Hoxlike homeodomain gene whose expression was initially described to be restricted to the pancreas and duodenum, and it has been demonstrated that pancreas development requires IDX1/IPF1 in mice (1, 2) . This requirement was confirmed in the human by the identification of an individual with pancreatic agenesis and a homozygous mutation in the IPF-1 gene (3). In addition, IDX1/IPF1 is essential for normal pancreatic islet function by regulating the expression of a number of pancreatic genes, including insulin, somatostatin, islet amyloid polypeptide and glucose transporter type 2 (4) (5) (6) (7) (8) . Importantly, in humans, heterozygous mutations of the IPF-1 gene are linked to a type of autosomal dominant diabetes mellitus known as maturity onset diabetes of the young (MODY4) (9) .
In the developing neural tube, different homeodomain genes that control mechanisms of regional and cellular determination are selectively expressed in the primordia of the three major regions of the CNS: forebrain, midbrain and hindbrain (10) . In the hindbrain, certain Hox-like homeodomain genes specify positional information utilized by neural precursor cells to develop into appropriate types of neurons or glial cells (11) . A similar type of code involving LIM-and Pax-homeodomain genes operates in the spinal cord (12) . In the midbrain, proper development requires the expression of engrailed genes (13, 14) .
In the forebrain, expression of most Hox genes is not readily detectable. However, other classes of mammalian homeobox genes, including Nkx, Otx, Emx and Dlx, show restricted patterns of expression preferentially located in the forebrain (15) , and are required for the development of forebrain structures (16) (17) (18) or for the differentiation of specific cell types in 4 different regions of the brain (18, 19) . In addition, homeodomain transcription factors of two other classes (POU and Pax) are important for forebrain development (20) (21) (22) (23) .
In a preliminary study, we found that expression of IDX1/IPF1 during embryonic development occurs in the CNS as well as in the pancreas (24) . In the present study, we provide evidence that the somatostatin gene is a target for regulation by IDX1/IPF1 in neural cells, and that neural expresion of IDX1/IPF1 is spacially and temporally regulated during CNS development. Thus, our data reinforce the notion that the transcriptional functions of IDX1/IPF1 are broader than previously anticipated, as they indicate the likelihood that IDX1/IPF1 plays a role in neural development.
EXPERIMENTAL PROCEDURES
RT-PCR/Southern blot hybridization analyses. Developing brains from rat embryos removed at different gestation times from timed-pregnant Sprague-Dawley rats were dissected under the microscope and the meningeal membranes were carefully removed. Brains of E16 and E19 embryos were further dissected into two parts by a transverse section made at the level of the caudal edge of the cerebral cortex. The piece rostral to this cut was labeled as forebrain, and the piece caudal to this cut was labeled as hindbrain. In addition, brains were removed from adult rats and several brain regions were dissected as described (25) . Total RNA (10 µg) from individual samples was incubated with poly-(dT) 15 and avian myeloblastosis virus reverse transcriptase to synthesize cDNA.
For PCR amplification of IDX1/IPF1, two different sets of primers were used in independent experiments, yielding identical results. In the first set, a forward primer that corresponds to nucleotides 90 to 117 (5'-CGGCTGCAACCATGGATAGTGAGGAGCAG-3'), and a reverse primer that anneals to nucleotides 280 to 296 (5'-AAGTCCCCCGGACATCT-3') of the published cDNA (6) were used. In the second set, a forward primer that corresponds to nucleotides 96 to 118 (5'-CCACCATGAATAGTGAGGAGCA-3'), and a reverse primer that anneals to nucleotides 305 to 322 (5'-GGCGAGCGGGGGCACTTC-3') were used. In both cases PCR conditions were: 98 °C for 1 min, followed by 30 cycles of 96° C for 30 sec, 56° C for 30 sec, and 75° C for 1 min, after which a 5 min incubation at 75° C followed. After PCR, an aliquot of the reaction was resolved in a 1% agarose gel, blotted onto a nylon membrane, probed with a 32 P-labeled internal primer that anneals to nucleotides 216 to 236 (5'-GCCGCCAGCCCCCACCTCCGC-3'), and autoradiographed at -70° C.
Primers for PCR amplification of Emx-1 and Dlx-2 were designed based on the published sequences of the rat cDNAs (26) . Emx-1 forward primer (nucleotides 10 to 31): 5'-CCTGGCTGGCTGGGTGCACACC-3'; reverse primer (nucleotides 278 to 289): 5'-CCACTCACGAAGGCCGCCTCG-3'. PCR conditions were: 94 °C for 5 min, followed by 30 cycles of 96° C for 30 sec, 65° C for 30 sec, and 75° C for 1 min, after which a 5 min incubation 6 at 75° C followed. As a probe to detect the PCR product after blotting onto nylon, the following 32 P-labeled internal primer was used: 5'-CACTCCTCTTCGGCGGCAGCG-3'. Dlx-2 forward primer (nucleotides 1 to 23): 5'-ACAGCCATGTCTGCTTAGACCAG-3'; reverse primer (nucleotides 298 to 321): 5'-TTCACGCCGTGATACTGATACTGG-3'. PCR conditions were:
98 °C for 1 min, followed by 30 cycles of 96° C for 30 sec, 60° C for 30 sec, and 75° C for 1 min, after which a 5 min incubation at 75° C followed. The 32 P-labeled internal primer used as a probe to detect the PCR product was 5'-ACTTCCAAGCTCCGTTCCCGA-3'.
For PCR amplification of actin, the primers used were as follows: Forward, 5'-GACGATATGGAGAAGATTTGGCA-3', which anneals to exon 2; Reverse, 5'-CCATCTCTTGCTCGAAGTCTAGG-3', which anneals to exon 3. The following protocol was used: 94°C for 5 min, followed by 20 cycles of 95°C for 30 sec, 50°C for 30 sec, and 72°C for 30 sec, after which a 5 min incubation at 72°C followed. As a probe to detect the PCR product after blotting onto nitrocellulose, the following 32 P-labeled internal primer was used: 5'-
In all cases, controls were carried out in which samples were treated with RNase A prior to cDNA synthesis to rule out genomic DNA contamination. In preliminary experiments, different numbers of PCR cycles were tested to ensure that the resulting signal in most samples does not increase to saturation.
Western immunoblots. Brain samples or cell lines were lysed in buffer containing 125 mM TrisHCl (pH 6.8), 4% SDS, 15% glycerol, 10% β-mercaptoethanol, and 10 mM dithiothreitol.
Proteins were resolved by SDS-PAGE and blotted onto a nitrocellulose membrane.
Immunoreactivity was detected with the α253 antiserum (1:10,000 dilution) (3, 27) , and visualized by enhanced chemiluminescence (ECL, Amersham, Buckinghamshire, England).
DNA-Protein binding assays. Electrophoretic mobility shift assays (EMSA) were carried out with nuclear extracts of rat developing forebrains or RC2.E10 cells exactly as described (28) . For 7 competitions, wild type, mutated TAAT oligonucleotides (6, 28) , or non-specific oligonucleotides of unrelated sequences were used. The sequences of all the oligonucleotides used have been published previously (6, (28) (29) (30) .
Cell lines and transfections. Neural RC2.E10 cells derived from rat E16 embryonic cortex (28) , and rat pancreatic islet somatostatin-producing RIN-1027-B2 cells (31) were used and cultured as described. All plasmids and transient transfections of RC2.E10 cells using Lipofectin (Gibco Laboratories, Grand Island, N.Y.) have been described (6, 28) .
Immunohistochemistry. Rat fetuses of different ages were removed from timed-pregnant Sprague-Dawley rats and fixed overnight in 4% paraformaldehyde. After fixation, they were washed with phosphate-buffered saline (PBS), transferred to PBS containing 20% sucrose, and kept at 4°C for at least 24 hours. Sagittal cryostat sections (10 µm) were cut and kept at -80°C until used. Sections were brought to room temperature, permeabilized with methanol for 2 min at -20° C, treated with 5% normal goat serum and then incubated overnight with the α253 anti-IDX1/IPF1 antiserum (1:1500 dilution) at 37°C. Immunodetection was carried out with a secondary biotinylated goat antirabbit antiserum (Bio-Rad Laboratories, Hercules, CA) using nickel-intensified immunoperoxidase staining with a Vectastain ABC kit (Vector Laboratories, Burlingame, CA). Two-color dual antigen immunostaining was carried out serially as described (32) . First, somatostatin was detected with a specific monoclonal rat antiserum (33) diluted 1:100, using immunoperoxidase staining enhanced with nickel ammonium, which yields a dark blue color.
Sections were then washed, and IDX1/IPF1 immunohistochemistry proceeded as described above, using immunoperoxidase staining without nickel ammonium, yielding a brown color.
Degenerate RT-PCR. Three regions of the rat brain, cortex, hippocampus and hypothalamus/thalamus, were dissected essentially as described (34, 25) , with the exception that 8 only parietal cortex was taken, and that the hypothalamus/thalamus was dissected as a single block of tissue. Total RNA (10 µg) purified by CsCl gradient centrifugation from each one of these regions was primed with poly-(dT) 15 and incubated with avian myeloblastosis virus reverse transcriptase (Boehringer Mannheim Biochemicals, Indianapolis, IN) to synthesize cDNA. One tenth of this cDNA preparation was used for PCR, using degenerate oligonucleotides corresponding to conserved residues found in helices 1 and 3 of Hox-like homeodomains. A control sample that lacked RNA was processed in parallel. The resulting PCR products were ligated into pBluescript (KS) (Stratagene, La Jolla, CA), and after transforming E. coli JM109, 25-30 individual colonies corresponding to each brain region were randomly picked, and plasmid minipreps were prepared and sequenced using the dideoxy chain termination method (Sequenase kit; US Biochemicals, Cleveland, OH). Degenerate oligonucleotide sequences, PCR conditions and subcloning procedure were exactly as described (6, 35) . Sequences were compared with GenBank database by using the BLAST Network Service provided by the National Center for Biotechnology Information.
RESULTS

Expression of IDX1/IPF1 in the developing CNS
To confirm that IDX1/IPF1 is expressed in the brain we carried out RT-PCR/Southern blot hybridization analysis with specific primers to IDX1/IPF1, using embryonic as well as adult rat brains. As a control to monitor developmental changes in homeodomain gene expression, we determined, in parallel experiments using the same template for RT-PCR reactions, the expression of Emx-1 and Dlx-2, two homeodomain genes known to be expressed restrictively in telencephalic areas of the developing brain (18, 19, (36) (37) (38) . As expected, Emx-1 and Dlx-2 transcripts were present in the brains of embryonic day 14 (E14) and E15 rats, enriched in the forebrain relative to the hindbrain (Fig. 1, E16 and E19). We found that IDX1/IPF1 transcripts are present in the brains of E14 and E15 rats ( Fig. 1) . In contrast to Emx-1 and Dlx-2, there was no difference in the levels of expression of IDX1/IPF1 between forebrain and hindbrain at E16.
Finally, at E19, expression of Emx-1 and Dlx-2 was robust and restricted to the forebrain, but IDX1/IPF1 levels had decreased both in the forebrain and in the hindbrain (Fig. 1 ).
In the adult brain, IDX1/IPF1 transcripts appeared to be of relatively low abundance in most regions examined, with the exception of the cerebellum (Fig. 1) . As expected, Emx-1 and Dlx-2 were found preferentially expressed in telencephalic areas (hippocampus, striatum and cortex) (Fig. 1 ).
Immunochemical detection of IDX1/IPF1 protein in neural cells was carried out initially by Western immunoblotting using an antiserum (α253) that recognizes specifically the Cterminal 12 amino acids of IDX1/IPF1 (3, 27) . Western immunoblot analysis confirmed that this antiserum recognizes both IDX1/IPF1 synthesized in vitro, and IDX1/IPF1 constitutively expressed in pancreatic islet-derived RIN-1027-B2 cells (Fig. 2) , a cell line from which IDX1/IPF1 was originally cloned (6) . In addition, we detected immunoreactive IDX1/IPF1 in nuclear extracts of E15 and E17 rat brains, as well as in nuclear extracts of RC2.E10 cells (Fig.   2) , a neural precursor cell line derived from rat embryonic cortex (28, 73) .
The finding of IDX1/IPF1 in RC2.E10 cells, which express the somatostatin gene in a neural-specific manner (28) , prompted us to explore the possibility that IDX1/IPF1 regulates somatostatin gene expression in neural cells.
IDX1/IPF1 present in neural cells binds to somatostatin gene DNA-regulatory elements
The promoter region of the somatostatin gene contains at least four homeodomainbinding DNA regulatory elements with a common TAAT core motif, named SMS-UE-B, SMS-TAAT1, SMS-TAAT2, and SMS-TAAT3, some of which appear to act as targets for regulation of somatostatin gene expression by IDX1/IPF1 in pancreatic cells (5, 6, 28, 30, 39) . We sought to investigate whether IDX1/IPF1 expressed in developing neural tissue is able to bind to these elements.
Initially, we determined by EMSA that nuclear extracts prepared from embryonic rat brains contain proteins that recognize synthetic oligonucleotides corresponding to these TAAT sites. Several specific DNA-protein complexes, distributed in three different clusters of slow (cluster 1), medium (cluster 2) and fast (cluster 3) relative electrophoretic mobility, were found to bind to SMS-TAAT1 (Fig. 3A) . No appreciable differences were observed between brain nuclear extracts prepared from E14 or E16 embryos (Fig. 3A) . A similar pattern was found when the SMS-TAAT2 probe was used, with the exception that the bands corresponding to complex 1 were not detected (Fig. 3B) .
When the SMS-TAAT3 probe was used, only two major protein-DNA complexes with relatively slow electrophoretic migration were detected in brain nuclear extracts from E14 or E16 embryos (Fig. 3C) . Finally, two complexes were found to bind to SMS-UE-B in brain nuclear extracts from E14 embryos, but only one was detected when brain nuclear extracts were prepared from E16 embryos (Fig. 3D ).
To investigate whether any of the complexes observed with embryonic brain nuclear extracts contain IDX1/IPF1, we carried out EMSA in the presence of the α253 antiserum, or in the presence of a different anti-IDX1/IPF1 antiserum (α251) which specifically recognizes the N-terminal 12 amino acids of IDX1/IPF1 (3, 27) . The addition of either of these antisera to the binding reaction did not disturb the protein complexes bound to SMS-TAAT1 and SMS-TAAT2
(not shown). However, we found that the presence of either of these antisera in the binding reaction results in the disappearance of the upper band detected with the SMS-TAAT3 (Fig. 4A) or with the SMS-UE-B probes (Fig. 4B) . Similar results were obtained when nuclear extracts from neural RC2.E10 cells, which express the somatostatin gene (28) , where used (not shown).
Thus, these experiments identify IDX1/IPF1 as a homeodomain transcription factor that binds somatostatin gene regulatory elements in neural cells.
IDX1/IPF1 activates somatostatin gene expression in neural cells
We carried out transient transfection experiments to evaluate the transactivational activity of IDX1/IPF1 on the somatostatin gene. First, we confirmed that transfection of RC2.E10 cells with pBJ5-IDX-1 (6), an expression plasmid encoding IDX1/IPF1, results in elevated levels of IDX1/IPF1 expression (Fig. 5A) . We then cotransfected increasing amounts of the pBJ5-IDX-1 plasmid with a fixed amount of plasmid SMS900, a chloramphenicol acetyl transferase (CAT) reporter plasmid which contains a fragment of the somatostatin gene spanning nucleotides -900 to +54 (40) . Expression of SMS900 after transient transfections in RC2.E10 cells has previously been characterized (28) . Cotransfection of pBJ5-IDX-1 and SMS900 resulted in a concentrationdependent increase in the levels of CAT activity (Fig. 5C ).
To determine whether any of the TAAT-containing elements of the somatostatin gene promoter are important for IDX1/IPF1 transactivation in neural cells, we carried out another series of transient cotransfection experiments in RC2.E10 cells, using mutant SMS900 plasmids in which each one of the TAAT motifs had been altered by site-directed mutagenesis in such a way that binding of nuclear proteins is impaired (28) .
Disruption of either SMS-TAAT1 or SMS-TAAT2 (Fig 5D) , or of both elements together (not shown), did not alter the transactivation activity of IDX1/IPF1. However, disruption of either SMS-TAAT3 or SMS-UE-B independently, inhibited the increase in the levels of CAT activity elicited by cotransfection with pBJ5-IDX-1 (Fig. 5D) , indicating that the integrity of these elements is required for the transactivation of the somatostatin gene by IDX1/IPF1 in neural cells.
Distribution of IDX1/IPF1-expressing cells in the developing brain
To gain information on the regional distribution of cells expressing IDX1/IPF1 in the developing CNS, we carried out immunohistochemistry on sagittal sections of rat embryos. As expected, we observed IDX1/IPF1 immunoreactivity in the duodenum and pancreatic mesenchyme (not shown). In the developing CNS, we found IDX1/IPF1 expressed in several regions.
In the telencephalon, cells with IDX1/IPF1 immunopositive nuclei were readily detectable throughout the depth of the neocortical neuroepithelium of E14 and E15 embryos (Fig. 6A) . At E15, a higher density of cells was often found clustering in the subventricular zone (Fig. 6A) . The intensity of immunostaining and relative number of immunopositive cells decreased at E16. In the neocortical epithelium of these embryos, IDX1/IPF1-positive cells were restricted to the ventricular and subventricular zones, and by E17 IDX1/IPF1 immunoreactivity in the neocortex was practically undetectable (Fig. 6A) , and positive nuclei were observed only occasionally. IDX1/IPF1 was also found expressed in the archicortex, which corresponds to the hippocampal primordium (Fig. 6B) , as well as in the germinative layers of the medial and lateral ganglionic eminence corresponding to the striato-pallidal primordium that generates the basal ganglia (Fig. 6B) . However, at E17 IDX1/IPF1 expression in the hippocampus and basal ganglia was undetectable (not shown).
IDX1/IPF1 immunoreactivity was also found in periventricular areas of the hypothalamus of E14 and E15 embryos, in scattered cells surrounding the optic, mammillary and infundibular recesses (not shown), as well as in the anterior hypothalamic neuroepithelium and the tuberal hypothalamus, where the highest density of cells with immunopositive nuclei was observed (Fig.   6B ). No IDX1/IPF1 immunoreactivity was detected in the hypothalamus of E17 embryos.
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In the mesencephalon, IDX1/IPF1 immunopositive cells were found in the pretectum and in the tectum, as well as in the tegmental neuroepithelium (Fig. 6B) . In rostral areas (pretectum and superior colliculus), expression decreased as development proceeded, so that in E17 embryos a relatively smaller number of positive cells were detected. In contrast, IDX1/IPF1 immunoreactivity in the caudal mesencephalon did not decrease, and many immunopositive cells were detected in the inferior colliculus of E17 embryos (Fig. 6C ).
More caudally, expression of IDX1/IPF1 was found in the cerebellar primordium of E14
(not shown) and E15 embryos, in cells that were located close to the ventricular surface (Fig.   6B ). No immunoreactivity was detected in E17 embryos.
Finally, intensely immunoreactive cells restricted to the area postrema appeared late in development (Fig. 6C) . Also, in E17 embryos immunopositive cells were detected in the developing pineal gland (Fig. 6C) .
Coexpression of IDX1/IPF1 and somatostatin in neural cells
In pancreatic cells, IDX1/IPF1 regulates somatostatin gene expression (5, 6, 39) . In the CNS, somatostatin expression first appears at E14, and its developmental pattern of expression coincides with the spatial and temporal pattern that we found for IDX1/IPF1 (41) (42) (43) . Therefore, we sought to determine whether somatostatin and IDX1/IPF1 are coexpressed in the same cells in the CNS during embryonic development. The presence of somatostatin-immunoreactive cells in different brain regions of E15 embryos, including ganglionic eminence, cortex (Fig. 7) , hypothalamus and mesencephalon (not shown), was confirmed a priori by standard immunohistochemistry. Dual antigen immunohistochemistry revealed the presence of immunopositive cells for both somatostatin and IDX1/IPF1 in these areas (Fig. 7) . The vast majority of somatostatin-positive cells stained positively for IDX1/IPF1, strongly supporting the notion that IDX1/IPF1 may also regulate somatostatin gene expression in neural cells. In addition, we detected a number of cells that showed IDX1/IPF1-positive nuclei, but did not stain for somatostatin (Fig. 7) .
Expression of Hox-like genes in brain tissue
To further investigate the expression of IDX1/IPF1 and other Hox genes in the forebrain, we carried out RT-PCR using RNA purified from three different adult brain regions. As PCR primers, we used degenerate oligonucleotides encoding the sequences ELEKE and KIWFQN, conserved in the homeodomains of Hox-like proteins. Sequence analyses of individual clones prepared from the resulting PCR products revealed the presence of several Hox-like genes expressed in each of the different brain regions analyzed (Table 1 ).
In the hypothalamus/thalamus region, 52% of the clones sequenced encode the homeodomain of Gbx-2, also known as MMox-A (44), and 12% of the clones encode MAB26.
Both of these Hox-like homeodomain sequences had been previously found expressed in developing mouse telencephalon using different degenerate primers (44) . In addition, Gbx-2 has been shown to be expressed in the diencephalic area that contains the prospective dorsal thalamus in mouse embryos (36, 45) . MAB26 was the most frequently found clone in the hippocampus, followed by HoxA1 (Table 1) . HoxA1 was also found with relatively high frequency (28%) in the cortex. However, in this region the most frequently found sequence (34%) encoded the homeodomain of IDX1/IPF1.
DISCUSSION
Although expression of the homeodomain transcription factor IDX1/IPF1 has been described to be restricted to the foregut and pancreas, we reported recently evidence indicating its expression also in the developing CNS (24) . This study demonstrates that expression of IDX1/IPF1 in neural cells is developmentally regulated in a region-and time-specific manner. In the cortex, ganglionic eminence and hypothalamus, expression decreases as development proceeds, whereas in other areas such as the inferior colliculus and area postrema, expression progressively increases or appears later in development, respectively. This dual mode of expression is reminiscent of the pattern of IDX1/IPF1 expression in the pancreas. At early stages, it occurs in proliferative cells of the growing pancreatic primordium in both exocrine and endocrine compartments (1, 2), but subsequently it is restricted to cells in the islets of Langerhans, consistent with two independent functions, one related to the genesis of insulinproducing β-cells, and the other related to the maintenance of their phenotype and of glucose homeostasis (46, 47) . Expression of IDX1/IPF1 in cells of the germinative zone of the ganglionic eminence coincides with a peak of neurogenesis in this structure (54) (55) (56) (57) . It has been suggested that other homeodomain proteins of different families (POU, Lhx, and Dlx), also expressed in the germinative zone at this time, participate in the initiation of the differentiation program of proliferating precursors (18, 20, 22, 58) . Thus, IDX1/IPF1 could act coordinately with some of these transcription factors to generate combinatorial codes for the selective regulation of specific genes. Interestingly, striatal somatostatin-expressing interneurons are generated at this time (56, 57) .
In the cortex, IDX1/IPF1 was found in cells of the proliferating neuroepithelium, often close to the ventricular surface (E14 and E15), but not in layers distal to the intermediate zone (E16). Thus, IDX1/IPF1 appears to be down-regulated as differentiating precursors or young neurons migrate through the cortex. In the rat, cortical neurogenesis takes place up until E20 (20, 59 ), but expression of IDX1/IPF1 was practically undetectable by E17. Therefore, the observed pattern of IDX1/IPF1 expression in the developing cortex is consistent with a role in neural precursors that generate specific types of neurons during a restricted period of time, but not in the maintenance of their mature phenotype. One of these types may correspond to somatostatinproducing neurons. Like IDX1/IPF1, somatostatin gene expression in many cells of the developing brain is transient, so that the relative number of somatostatin-expressing cells in the mature cortex is lower than that present during corticogenesis (41, 43, 60, 61) .
We found a number of cells that stain for IDX1/IPF1 but not for somatostatin in all areas examined. Thus, IDX1/IPF1 probably regulates the expression of other genes in the CNS, but their identities are unknown. Nonetheless, that the somatostatin gene is a target for regulation by IDX1/IPF1 in neural cells is further supported by our EMSA and transfection studies using somatostatin-expressing cortex-derived RC2.E10 cells.
One function of IDX1/IPF1 is to participate in the homeostatic control of normoglycemia by coordinately regulating the expression of several genes involved in glucose-sensing mechanisms and glucose utilization in the pancreas (46, 47) . The brain acts as a center for the integration of information pertaining to fuel metabolism and energy homeostasis (62) . In particular, the area postrema contains glucose-responsive neurons, and the hypothalamus contains glucose-, glucagon-like peptide-1-, and leptin-responsive neurons, that may play a role in the central control of food intake and maintenance of normoglycemia (63) (64) (65) (66) . Our finding of IDX1/IPF1 in the developing hypothalamus and area postrema, suggests that one putative function of IDX1/IPF1 in the embryo may be the development of an integrated system of cells located both in the CNS and in the periphery, to coordinately regulate glucose uptake and metabolism.
The effects of the inactivation of IDX1/IPF1 on pancreas development have been assessed in detail in mutant mice (1, 2, 46, 47) , but no studies on the development of the CNS in those mice have been reported. IDX1/IPF1 mutant mice exhibit lack of pancreas and early postnatal lethality (1, 2) , preventing the finding of any possible neural deficit. However, possible defects due to lack of IDX1/IPF1 in the CNS may be subtle and not readily apparent unless purposely studied in detail, as it is the case for other homeodomain genes (18, 19).
Several genes encoding transcription factors, including Nkx2.2, Isl-1, and BETA2/NeuroD, are restrictively expressed in both developing pancreas and CNS. Targeted disruption of the Isl-1 gene results in early arrest of pancreatic development and embryonic lethality (67) . Like mice lacking IDX1/IPF1, mice with inactivation of the genes encoding BETA2/NeuroD or Nkx2.2 develop severe neonatal diabetes, due to alterations in pancreatic 18 development, and die postnatally (68, 69) . In the CNS, lack of BETA2/NeuroD or Nkx2.2 results in alterations in the differentiation of specific populations of neural cells (70, 71) . Whether neural alterations in specific areas of the CNS contribute to the observed early postnatal lethality of these mice remains unknown. Thus, the possibility of specific defects in the CNS of IDX1/IPF1 mutant mice merits further detailed investigation.
The finding of a human subject with a homozygote mutation in IDX1/IPF1 and pancreatic agenesis led to the proposal that other genes such as BETA2/NeuroD or Nkx2.2 may also be candidates for human neonatal diabetes (69) . It is noteworthy that, although this is a rare condition, a recent survey of reported cases revealed that a significant proportion of patients (at least 20%) exhibit signs of neural defects including impaired mental and motor development (72) . This observation, together with the findings reported in this study, support the notion that some elements of the transcriptional control of neuronal and pancreatic differentiation are conserved (67) , despite the different ontogenic origins of these tissues. 
